The Mitraclip procedure is at present the most widely available method for transcatheter correction of severe mitral regurgitation (MR). The efficacy and the safety of the device has been evaluated in the EVEREST II randomized control study1 (head to head comparison with traditional surgical repair or replacement of the mitral valve) and although not as effective in abolishing MR, it provided significant improvement in functional class, along with evidence of favorable ventricular remodeling and with low perioperative morbidity and mortality.
Background There is limited information on the long-term outcomes and prognostic clinical predictors...
ObjectiveThe Endovascular Valve Edge-to-Edge Repair Study (EVEREST II) is a prospective, multicenter...
OBJECTIVES: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study (HRS) assessed t...
The Mitraclip procedure is at present the most widely available method for transcatheter correction ...
Transcatheter mitral valve repair (TMVR) with MitraClip is a therapeutic option for high surgical ri...
Objectives: To determine the efficacy of the MitraClip device in the reduction of mitral regurgitati...
High-risk patients with mitral regurgitation (MR) can be treated with the MitraClip treatment. Two m...
Transcatheter MitraClip repair is a new tool for the management of severe mitral regurgitation in pa...
Background: Available scientific evidence of transcatheter mitral valve repair with the MitraClip co...
Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular d...
ObjectivesThe aim of this study was to assess the outcomes of patients at prohibitive surgical risk ...
Transcatheter mitral valve repair with MitraClip is a novel, intricate therapy for mitral regurgitat...
AIMS The Swiss national registry on percutaneous mitral valve interventions (MitraSwiss) was establ...
Background. MitraClip (MC) therapy is now established as a secure, feasible treatment option for pa...
ObjectivesThe EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study (HRS) assessed the...
Background There is limited information on the long-term outcomes and prognostic clinical predictors...
ObjectiveThe Endovascular Valve Edge-to-Edge Repair Study (EVEREST II) is a prospective, multicenter...
OBJECTIVES: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study (HRS) assessed t...
The Mitraclip procedure is at present the most widely available method for transcatheter correction ...
Transcatheter mitral valve repair (TMVR) with MitraClip is a therapeutic option for high surgical ri...
Objectives: To determine the efficacy of the MitraClip device in the reduction of mitral regurgitati...
High-risk patients with mitral regurgitation (MR) can be treated with the MitraClip treatment. Two m...
Transcatheter MitraClip repair is a new tool for the management of severe mitral regurgitation in pa...
Background: Available scientific evidence of transcatheter mitral valve repair with the MitraClip co...
Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular d...
ObjectivesThe aim of this study was to assess the outcomes of patients at prohibitive surgical risk ...
Transcatheter mitral valve repair with MitraClip is a novel, intricate therapy for mitral regurgitat...
AIMS The Swiss national registry on percutaneous mitral valve interventions (MitraSwiss) was establ...
Background. MitraClip (MC) therapy is now established as a secure, feasible treatment option for pa...
ObjectivesThe EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study (HRS) assessed the...
Background There is limited information on the long-term outcomes and prognostic clinical predictors...
ObjectiveThe Endovascular Valve Edge-to-Edge Repair Study (EVEREST II) is a prospective, multicenter...
OBJECTIVES: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study (HRS) assessed t...